Van Tuyl Christopher bought IMVT
June 26, 2026 · Form 4 insider transaction
Van Tuyl Christopher bought 17,824 shares of Immunovant, Inc. at $15.20 per share, a transaction worth $270.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,824
Price
$15.20
Total value
$270.9K
InsiderVan Tuyl Christopher
Role—
CompanyImmunovant, Inc. (IMVT)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 26, 2026
Filing dateJune 26, 2026
Shares owned after198,421
OwnershipDirect
10b5-1 planNo
AmendedNo